tiprankstipranks
Legend Biotech’s CARVYKTI Shows Promising Myeloma Results
PremiumCompany AnnouncementsLegend Biotech’s CARVYKTI Shows Promising Myeloma Results
18d ago
Legend Biotech appoints Alan Bash as president of Carvykti
Premium
The Fly
Legend Biotech appoints Alan Bash as president of Carvykti
19d ago
Legend Biotech participates in a conference call with JPMorgan
Premium
The Fly
Legend Biotech participates in a conference call with JPMorgan
26d ago
Legend Biotech Reports Strong CARVYKTI® Sales Growth
PremiumCompany AnnouncementsLegend Biotech Reports Strong CARVYKTI® Sales Growth
1M ago
Legend Biotech initiated with a Buy at Redburn Atlantic
Premium
The Fly
Legend Biotech initiated with a Buy at Redburn Atlantic
2M ago
Legend Biotech to open cell therapy R&D facility in Philadelphia
Premium
The Fly
Legend Biotech to open cell therapy R&D facility in Philadelphia
2M ago
Legend Biotech’s New Cancer Drug Wins Approval
PremiumCompany AnnouncementsLegend Biotech’s New Cancer Drug Wins Approval
3M ago
Legend Biotech price target raised to $76 from $70 at Scotiabank
Premium
The Fly
Legend Biotech price target raised to $76 from $70 at Scotiabank
3M ago
Morning Movers: Iteris skyrockets following take-private agreement
Premium
The Fly
Morning Movers: Iteris skyrockets following take-private agreement
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100